:


Bajorin D, Sarosdy , Pfister et al. Randomized trial of etoposide and cis- platin versus etoposide and carboplatin in patients with good- risk germ cell tumors. J Clin Oncol 1993; 11:598.

Bhatia S, Porcu P, Cornetta Abonour R, Beshadri R, Nichols CR, and Einhorn LH. High dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer. J Clin Oncol 2000; 18:3346.

Bosl GJ, Motzer RJ. Testicular germ cell cancer. N Engl J Med 1997; 337:242.

Einhorn LH. Curing cancer. Testicular cancer. Proc Nat Acad Sci 2002; 99:4592.

Fossa SD, Horwich A, Russell JM, et al.: Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. J Clin Oncol 1999; 16:1146.

Hinton S, Catalano P, Einhorn LH, et al.: Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors: A trial of the Eastern Cooperative Oncology. J Clin Oncol 2002; 20:1859.

International Germ Cell Collaborative Group. International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997; 15:594.

Loehrer PJ, Gonin R, Nichols CR, et al. Vinblastine plus ifosphamide plus cisplatin as initial salvage therapy in recurrent germ cell tumors. J Clin Oncol 1998; 16:2500.

Motzer RJ, Sheinfeld J, Mazumdar M, et al: Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer. J Clin Oncol 2000; 18:2413.

Williams SD, Birch R, Einhorn LH, et al. Treatment of disseminated germ cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 1987; 316:1435.

: